Market Overview

Benzinga's Top Downgrades

Share:
Related BMRN
BioMarin (BMRN) Down 8% Since Earnings Report: Can It Rebound?
Mark Your Calendar For These Days In May To Play The Volatility Around FDA Decision Dates
Too Late To Catch Biotech Rally As Trump Fears Subside? (Investor's Business Daily)
Related PEG
Mid-Day Market Update: Red Robin Surges After Strong Q1 Results; bebe stores Shares Slide
Earnings Scheduled For April 28, 2017

Analysts at Deutsche Bank downgraded BioMarin Pharmaceutical (NASDAQ: BMRN) from “buy” to “hold.” BioMarin's shares closed at $38.70 on Friday. BioMarin's trailing-twelve-month ROE is -11.59%.

Analysts at FBR Capital downgraded Public Service Enterprise Group (NYSE: PEG) from “market perform” to “underperform.” PSEG's stock closed at $32.13 on Friday. PSEG's PEG ratio is 6.66.

Analysts at KeyBanc Capital downgraded Ignite Restaurant Group (NASDAQ: IRG) from “buy” to “hold.” Ignite Restaurant's shares closed at $15.12 on Friday. Ignite Restaurant's trailing-twelve-month profit margin is 2.99%.

UBS downgraded Westlake Chemical (NYSE: WLK) from “neutral” to “sell.” Westlake Chemical's shares closed at $69.50 on Friday. Westlake Chemical's trailing-twelve-month ROA is 9.24%.

Latest Ratings for BMRN

DateFirmActionFromTo
Mar 2017UBSInitiates Coverage OnNeutral
Mar 2017NomuraInitiates Coverage OnNeutral
Feb 2017Morgan StanleyInitiates Coverage OnOverweight

View More Analyst Ratings for BMRN
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings

 

Related Articles (BMRN + IRG)

View Comments and Join the Discussion!